These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 15209898)
21. A flow cytometric method for detection and enumeration of low-level, residual red blood cells in platelets and mononuclear cell products. Santana JM; Dumont LJ Transfusion; 2006 Jun; 46(6):966-72. PubMed ID: 16734813 [TBL] [Abstract][Full Text] [Related]
22. Evaluating leucodepletion systems suitable for routine use. Rowe G Transfus Sci; 2000; 22(1-2):61-2. PubMed ID: 10771384 [No Abstract] [Full Text] [Related]
23. Recipiant and donor response to granulocyte transfusion and leukapheresis. Graham V; Rubal BJ Cancer Nurs; 1980 Apr; 3(2):97-100. PubMed ID: 6899976 [No Abstract] [Full Text] [Related]
24. Centrifugal leukocytapheresis and thrombocytapheresis: recommendations concerning donor safety, quality control of the prepared concentrate, and use of equipment. J Clin Apher; 1983; 1(3):117-195. PubMed ID: 6546050 [No Abstract] [Full Text] [Related]
25. Leucodepletion, bacterial testing and pathogen removal update and position for Scotland: April 2001. Prowse CV Transfus Apher Sci; 2001 Dec; 25(3):217-8. PubMed ID: 11846149 [No Abstract] [Full Text] [Related]
26. Leukocyte removal and its effects on immunomodulation. Nosé Y Artif Organs; 2010 Jun; 34(6):451-2. PubMed ID: 20624159 [No Abstract] [Full Text] [Related]
27. Selective or universal leucodepletion: the Italian experience. Accorsi P; Iacone A Transfus Sci; 2000; 22(1-2):65-7. PubMed ID: 10771386 [No Abstract] [Full Text] [Related]
28. Clinical and molecular basis of transfusion-induced immunomodulation: summary of the proceedings of a state-of-the-art conference. Blajchman MA; Dzik S; Vamvakas EC; Sweeney J; Snyder EL Transfus Med Rev; 2001 Apr; 15(2):108-35. PubMed ID: 11309732 [No Abstract] [Full Text] [Related]
29. Prestorage versus poststorage white cell reduction for the prevention of the deleterious immunomodulatory effects of allogeneic blood transfusion. Vamvakas EC; Blajchman MA Transfus Med Rev; 2000 Jan; 14(1):23-33. PubMed ID: 10669938 [No Abstract] [Full Text] [Related]
30. Leukocyte counting during process control of leukoreduced blood components. Dzik WH Vox Sang; 2000; 78 Suppl 2():223-6. PubMed ID: 10938957 [TBL] [Abstract][Full Text] [Related]
31. Is leukocyte depletion important in the prevention of alloimmunization by random single donor platelet transfusions? Gmür J; Schanz U; Burger J; Reichlin M; Müller E; Oelz O Infusionstherapie; 1991 Jun; 18 Suppl 1():13-8. PubMed ID: 1917058 [No Abstract] [Full Text] [Related]
32. [Problems in blood donors in plasmapheresis and cytopheresis]. Fiala J Vnitr Lek; 1982 Feb; 28(2):182-8. PubMed ID: 7064373 [No Abstract] [Full Text] [Related]
33. Evaluation of two types of leukocyte removal filters on transfusion dependent thalassaemics. Jamal R; Mazeni NR; Hussin H Malays J Pathol; 2000 Dec; 22(2):79-83. PubMed ID: 16329539 [TBL] [Abstract][Full Text] [Related]
34. Leucodepletion, bacterial contamination and viral inactivation: a Portuguese blood centre experience. Vasconcelos E Transfus Apher Sci; 2001 Dec; 25(3):215-6. PubMed ID: 11846148 [No Abstract] [Full Text] [Related]
36. [The clinical use of a leukocyte concentrate]. Ryzhkov SV; Kaleko SP; Plotskiĭ AN Vestn Khir Im I I Grek; 1992 Jan; 148(1):78-82. PubMed ID: 1338849 [No Abstract] [Full Text] [Related]